The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

The tariffs imposed by Trump were seen by some as an existential threat to the auto sector. Arthur Laffer, whom Trump gave ...

WASHINGTON (AP) — The Trump administration has frozen, stalled or otherwise disrupted some $430 billion in federal funds — ...

In addition to risking indigestion, you’re more likely to overeat because the fullness trigger hasn’t had time to activate ...

According to halacha, or traditional Jewish law, milk is only kosher if it comes from a kosher animal. One way to ensure that ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.